SEC registrant: REGENERON PHARMACEUTICALS, INC., CIK 872589. Common stock (inferred from the name, not yet reviewed). Issuer name and CIK from the SEC company list fetched 2026-09-05; the ticker match itself uses the exchange lists described on the methodology page.
Filed as: REGENERON PHARMACEUTICALS INC; Regeneron Pharmaceuticals, Inc. (REGN); REGENERON PHARMACEUTICALS INC UNSOLICITED.
| Date | Official | As filed | Type | Amount | Verification |
|---|---|---|---|---|---|
| June 16, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Sale | $1K-$15K | CheckedAn OCR program and an AI model each read this row and agreed. A page check confirmed this row. |
| June 12, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Sale | $100K-$250K | CheckedAn OCR program and an AI model each read this row and agreed. A page check confirmed this row. |
| May 11, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Purchase | $100K-$250K | CheckedAn OCR program and an AI model each read this row and agreed. A page check confirmed this row. |
| April 27, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Purchase | $15K-$50K | CheckedThe PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row. |
| April 15, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Purchase | $1K-$15K | CheckedAn OCR program and an AI model each read this row and agreed. A page check confirmed this row. |
| April 7, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC filing | Purchase | $1K-$15K | CheckedThe PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row. |
| March 2, 2026 | Donald J. Trump President of the United States | REGENERON PHARMACEUTICALS INC UNSOLICITED filing | Purchase | $15K-$50K | CheckedThe PDF parser could not read this filing reliably, so two AI models from different companies read it and agreed. A page check confirmed this row. |
| Sept. 10, 2025 | Bryan Bedford FAA Administrator | Regeneron Pharmaceuticals, Inc. (REGN) filing | Sale | $15K-$50K | CheckedA PDF parser and an AI model each read this filing and agreed on every row. A page check confirmed this row. |
| July 11, 2025 | Bryan Bedford FAA Administrator | Regeneron Pharmaceuticals, Inc. (REGN) filing | Purchase | $1K-$15K | CheckedA PDF parser and an AI model each read this filing and agreed on every row. A page check confirmed this row. |
Source: U.S. Office of Government Ethics. Values reported in ranges per federal law. A trade is listed here only when its printed name was read the same way by two independent readers and matched this security exactly, by symbol or by name on two reference lists, or a person confirmed it. Broker abbreviations still under review are not listed; the trades stay on the official’s page under the printed name.